Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1428-1434

  Nashleanas, Michelle ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY CD3; NITRIC OXIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; LEISHMANIA MAJOR; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; CD40 LIGAND; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; LEISHMANIA MAJOR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; T-LYMPHOCYTES;

EID: 0033984474     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1428-1434.2000     Document Type: Article

References (45)

1. Bachmann, M. F., B. R. Wong, R. Josien, R. M. Steinman, A. Oxenius, and Y. Choi. 1999. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189:1025-1031.
2. Belosevic, M., C. E. Davis, M. S. Meltzer, and C. A. Nacy. 1988. Regulation of activated macrophage antimicrobial activities: identification of lymphokines that cooperate with IFN-γ induction of resistance to infection. J. Immunol. 141:890-896.
3. Binnerts, M. E., Y. van Kooyk, D. L. Simmons, and C. G. Figdor. 1994. Distinct binding of T lymphocytes to ICAM-1, -2, or -3 upon activation of LFA-1. Eur. J. Immunol. 24:2155-2160.
4. Bogdan, C., H. Moll, W. Solbach, and M. Rollinghoff. 1990. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1131-1135.
5. Castle, B. E., K. Kishimoto, C. Stearns, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777-1788.
6. de Fougerolles, A. R., and T. A. Springer. 1992. Intracellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J. Exp. Med. 175:185-190.
7. de Fougerolles, A. R., S. A. Stacker, R. Schwarting, and T. A. Springer. 1991. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174:253-267.
8. Erickson, S. L., F. J. De Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
9. Garcia, I., Y. Miyazaki, K. Araki, M. Araki, R. Lucas, G. E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401-2407.
10. Green, L., D. Wagner, J. Glogowski, P. Skipper, J. Wishnok, and S. Tannebaum. 1982. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126:131.
11. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145:4290-4297.
12. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
13. Igietseme, J. U., I. M. Uriri, R. Hawkins, and R. G. Rank. 1996. Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J. Leukoc. Biol. 59:656-662.
14. Jackson, P. R., M. G. Pappas, and B. D. Hansen. 1985. Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Science 227:435-438.
15. James, S. L. 1995. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:533-547.
16. Kurose, I., H. Ebinuma, H. Higuchi, Y. Yonei, H. Saito, S. Miura, and H. Ishii. 1995. Nitric oxide mediates mitrochondrial dysfunction in hepatoma cells induced by non-activated Kupffer cells: an evidence implicating ICAM-1-dependent process. J. Gastroenterol. Hepatol. 10:S68-S71.
17. Kurose, I., H. Saito, S. Miura, H. Ebinuma, H. Hajime, N. Watanabe, S. Zeki, T. Nakamura, M. Takaishi, and H. Ishii. 1997. CD18/ICAM-1-dependent oxidative NF-κB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngenic hepatoma cells. J. Clin. Investig. 99:867-878.
18. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
19. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
20. Liew, F. Y., C. Parkinson, S. Millott, A. Severn, and M. Carrier. 1990. Tumor necrosis factor (TNFα) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis. Immunology 69:570-573.
21. Lub, M., Y. van Kooyk, and C. G. Figdor. 1995. Ins and outs of LFA-1. Immunol. Today 16:479-483.
22. MacMicking, J., Q. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
23. Nacy, C. A. 1984. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes. J. Immunol. 133:448-453.
24. Nacy, C. A., and C. L. Diggs. 1981. Intracellular replication of Leishmania tropica in suspension cultures of mouse peritoneal macrophages. Infect. Immun. 34:310-313.
25. Nashleanas, M., S. Kanaly, and P. Scott. 1998. Control of Leishmania major in mice lacking TNF receptors. J. Immunol. 160:5506-5513.
26. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Weignmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
27. Salomon, B., and J. A. Bluestone. 1998. Cutting edge: LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161: 5138-5142.
28. Sanchez-Madrid, F., P. Simon, S. Thompson, and T. A. Springer. 1983. Mapping of antigenic and functional epitopes on the α and β subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J. Exp. Med. 158:586-602.
29. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
30. Semnani, R. T., T. B. Nutman, P. Hochman, S. Shaw, and G. A. van Seventer. 1994. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells. J. Exp. Med. 180:2125-213.
31. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273.
32. Spink, J., and J. Evans. 1997. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272:24417-24425.
33. Starling, G. C., A. D. McLellan, W. Egner, R. V. Sorg, J. Fawcett, D. L. Simmons, and D. N. Hart. 1995. Intracellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells. Eur. J. Immunol. 28:2528-2532.
34. Stout, R. D., and K. Bottomly. 1989. Antigen specific activation of effector macrophages by interferon-IFN-γ producing (Th1) T cell clones. Failure of IL-4 producing (Th2) T cell clones to activate effector function in macrophages. J. Immunol. 142:760-765.
35. Stout, R. D., J. Suttles, J. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8-11.
36. Suttles, J., R. W. Miller, X. Tao, and R. D. Stout. 1994. T cells which do not express membrane tumor necrosis factor-α activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-α production. Eur. J. Immunol. 24:1736-1742.
37. Sypek, J. P., C. B. Panosian, and D. J. Wyler. 1984. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction. J. Immunol. 133:3351-3357.
38. Takei, F. 1985. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 134:1403-1407.
39. Thuring, H., S. Stenger, D. Gmehling, M. Rollinghoff, and C. Bogdan. 1995. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major infected mice. Eur. J. Immunol. 25:3229-3234.
40. Tian, L., R. J. Noelle, and D. A. Lawrence. 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306-309.
41. Titus, R. G., A. Kelso, and J. A. Louis. 1984. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin. Exp. Immunol. 55:157-165.
42. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:2097-2103.
43. Tushinski, R. J., I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71-81.
44. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827-835.
45. Yap, G. S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance of TNF receptor p55 and p75 deficient mice to chronic toxoplasmosis despite normal activation of iNOS in vivo. J. Immunol. 160:1340-1345.